<p>This is an all-COVID-19 week. We discuss the WHO Solidarity trial of remdesivir and other antivirals, banlamivimab for outpatients, and an RCT of convalescent serum. </p>

This is an all-COVID-19 week. We discuss the WHO Solidarity trial of remdesivir and other antivirals, banlamivimab for outpatients, and an RCT of convalescent serum.

<p>This is an all-COVID-19 week. We discuss the WHO Solidarity trial of remdesivir and other antivirals, banlamivimab for outpatients, and an RCT of convalescent serum.&nbsp;</p>

Episode 66: repurposed antivirals, banlamivimab for outpatients, and convalescent serum, all for COVID-19

Four healthily skeptical primary care physicians discuss the latest in primary care medicine. Join Essential Evidence Editor Mark Ebell MD, Rush University's Kate Rowland MD, MSU Professor of Medicine Gary Ferenchick MD, and POEMs co-founder Henry Barry MD, MS for this fast-paced weekly update on evidence-based primary care.

Share Episode 66: repurposed antivirals, banlamivimab for outpatients, and convalescent serum, all for COVID-19

Sign up to save your podcasts

Episode 66: repurposed antivirals, banlamivimab for outpatients, and convalescent serum, all for COVID-19

Episode 66: repurposed antivirals, banlamivimab for outpatients, and convalescent serum, all for COVID-19

More shows like Primary Care Update

JAMA Editors' Summary

NEJM This Week

JAMA Clinical Reviews

AFP: American Family Physician Podcast

Mayo Clinic Talks

Frankly Speaking About Family Medicine

The Curbsiders Internal Medicine Podcast

JAMA Medical News

Core IM | Internal Medicine Podcast

Annals On Call Podcast

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

Run the List

The Curious Clinicians

The Cribsiders